DuPont — the strategy behind it | Stratrix

Company profile

Industry: Plastic Materials, Synth Resins & Nonvulcan Elastomers
Listed: NYSE: DD
Incorporated: DE
Headquarters: Wilmington, DE
Fiscal year end: Dec 31

Financials

FY2025

Revenue: $6.85B
Net income: −$738.0M
Total assets: $21.6B

DuPont — reported revenue, net income and total assets by fiscal year, from SEC filings
Fiscal year	Revenue	Net income	Total assets
FY2025	$6.85B	−$738.0M	$21.6B
FY2024	$6.72B	$738.0M	$36.6B
FY2023	$6.61B	$462.0M	$38.6B
FY2021	$12.6B	$6.51B	$45.7B
FY2020	$11.1B	−$2.95B	$70.9B
FY2019	$15.4B	$498.0M	$69.3B

Reported fiscal years from SEC filings (10-K) — SEC EDGAR ↗. Stratrix is a strategy publication, not a real-time financial data service.

The analyses

The Adjacency Expansion · Growth & Portfolio

DuPont Keeps Promising One Last Breakup. There Is No Last Breakup.

Since 2015 DuPont has merged a $130B chemical giant and then unwound it into pieces — Chemours, Dow, Corteva, the M&M sale, the Electronics spin. Each 'New DuPont' is sold as the final, focused company. Then it announces the next split. The terminal state never arrives.

The Adjacency Expansion · Growth & Portfolio

DuPont Reinvented Itself for 200 Years. Almost Never on Purpose.

DuPont went from gunpowder to nylon to a three-way breakup that ended in 2019. The legend is visionary reinvention. The record says something colder: nearly every pivot was forced by a court, a war, or an activist, not chosen by a strategist.

The Crisis Response · Decision Forks

DuPont Kept the Science and Spun Off the Bill

DuPont's own lab flagged its 'forever chemical' as toxic in 1961, then withheld it for forty years. When liability became unavoidable, it carved off Chemours in 2015 with liabilities allegedly capped at $1.42 billion - a single case soon settled for $671 million.

The Fall · Decision Forks

The Dow Merger Dismantled 215-Year-Old DuPont — And Dismantling Was the Plan From Day One

DuPont was 215 years old in 2017. Then it merged with Dow and split into pieces in the name of unlocking value. The autopsy reveals no market killed it — a strategy did, and the strategy was the plan from day one.